Steven N. Blair
University of South Carolina
892 Papers
6.9K Citations
Steven N. Blair is an academic researcher from University of South Carolina. The author has contributed to research in topics: Medicine & Physical fitness. The author has an hindex of 165, co-authored 879 publications. Previous affiliations of Steven N. Blair include Stanford University & University of Western Australia.
Chat about Author
Papers
Exercise dose and quality of life: a randomized controlled trial.
TL;DR: Exercise-induced QOL improvements were dose dependent and independent of weight change, and higher doses of exercise were associated with larger improvements in mental and physical aspects of QOL.
Less Sitting, More Physical Activity, or Higher Fitness?
Claude Bouchard,Steven N. Blair,Peter T. Katzmarzyk +2 more
- 01 Nov 2015
TL;DR: It will be increasingly important for disease prevention, successful aging, and reduction of premature mortality to broaden the focus of the public health message to include not only more physical activity but also less sitting and higher cardiorespiratory fitness.
Long-term Impact of Cardiorespiratory Fitness on Type 2 Diabetes Incidence: A Cohort Study of Japanese Men.
Ryoko Kawakami,Susumu S. Sawada,I-Min Lee,I-Min Lee,Yuko Gando,Haruki Momma,Shin Terada,Chihiro Kinugawa,Takashi Okamoto,Koji Tsukamoto,Mitsuru Higuchi,Motohiko Miyachi,Steven N. Blair +12 more
TL;DR: High CRF is associated with a lower risk of the incidence of type 2 diabetes over an extended period of >20 years among men, and there was an inverse dose-response relationship between CRF and the development of type 1 diabetes for all three follow-up periods.
Comparison of the Cardiovascular Benefits of Resistance, Aerobic, and Combined Exercise (CardioRACE): Rationale, design, and methods
Angelique G. Brellenthin,Lorraine Lanningham-Foster,Marian L. Kohut,Yehua Li,Timothy S. Church,Steven N. Blair,Duck-chul Lee +6 more
TL;DR: CardioRACE will fill an important knowledge gap regarding the effects of RE, alone or in addition to the well-documented effects of AE, for CVD prevention and generate more comprehensive and synergistic clinical and public health strategies to prevent CVD.
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
Sidney C. Smith,Steven N. Blair,Robert O. Bonow,Lawrence M. Brass,Manuel D. Cerqueira,Kathleen Dracup,Valentin Fuster,Antonio M. Gotto,Scott M. Grundy,Nancy Houston Miller,Alice K. Jacobs,Daniel W. Jones,Ronald M. Krauss,Lori Mosca,Ira S. Ockene,Richard C. Pasternak,Thomas A. Pearson,Marc A. Pfeffer,Rodman D. Starke,Kathryn A. Taubert +19 more
TL;DR: Since the original publication (in 1995) of the AHA consensus statement on secondary prevention, important evidence from clinical trials has emerged that further supports the merits of aggressive risk reduction therapies for patients with atherosclerotic cardiovascular disease.